CareCloud (NASDAQ:CCLD) Third Quarter 2024 Results
Key Financial Results
- Revenue: US$28.5m (down 2.5% from 3Q 2023).
- Net loss: US$667.0k (loss narrowed by 90% from 3Q 2023).
- US$0.041 loss per share (improved from US$0.42 loss in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
CareCloud EPS Beats Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 71%.
Looking ahead, revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 9.7% growth forecast for the Healthcare Services industry in the US.
Performance of the American Healthcare Services industry.
The company's shares are up 5.8% from a week ago.
Risk Analysis
What about risks? Every company has them, and we've spotted 4 warning signs for CareCloud you should know about.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqGM:CCLD
CareCloud
A healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States.
Flawless balance sheet and undervalued.
